Network-Based Approaches for Drug Target Identification

Drug target identification is the first step in drug development, and its importance is underscored by the fact that, even when using genetic evidence to improve success rates, only a small fraction of lead targets end up approved for use in the clinic. One of the reasons for this is the lack of in-depth understanding of the complexity of human diseases.In this review we argue that network-based approaches, which are able to capture relationships between relevant genes and proteins, and diverse data modalities have high potential for improving drug target identification and drug repurposing. We present the evolution of network-based methods that have been developed for this purpose and discuss the limitations of these approaches that are holding them back from making an impact in the clinic. We finish by presenting our recommendations for overcoming these limitations, for example, by leveraging emerging technologies such as artificial intelligence and knowledge graphs.